Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06425094 · ClinicalTrials.gov registry record · NA
Effects of a Microalgae Extract Dietary Supplement on Gut Health, Anxiety, and Immune Function
A NA study, sponsored by Colorado State University.
- Completed
- Registry status
- NA
- Development phase
- 62
- Enrollment target
NCT06425094 is a NA study that has completed, run by Colorado State University. The registered enrollment target is 62 participants.
The verdict
NCT06425094, a NA study, has completed, sponsored by Colorado State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
Study Summary
This study will be conducted to determine the effect of daily Tetrasol consumption in supporting gut health using assessments of gastrointestinal symptoms (GSRS) and bowel habits (BSS) as primary outcome measures. The investigators also intend to explore fecal and blood biomarkers of intestinal permeability/function, determination of anxiety and stress levels through both validated assessments and saliva and blood biomarkers, establishment of intervention safety and tolerability through comprehensive metabolic panels and overall compliance, explore the effects of the intervention on inflammation and acute stress (Cold Presser Test), blood lipid profiles, and gut microbiota composition as secondary outcomes.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Microalgae Extract Capsules
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2024-02-05 |
| Est. Completion | 2025-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06425094
The ClinicalTrials.gov registry entry for NCT06425094 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Colorado State University, which has 94 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT06425094 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06425094 about?
NCT06425094 is a clinical study titled "Effects of a Microalgae Extract Dietary Supplement on Gut Health, Anxiety, and Immune Function". This study will be conducted to determine the effect of daily Tetrasol consumption in supporting gut health using assessments of gastrointestinal symptoms (GSRS) and bowel habits (BSS) as primary outcome measures. The investigators also intend to explore fecal and blood biomarkers of intestinal perm...
What is the current status of trial NCT06425094?
This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2024-02-05. Estimated completion is 2025-01-31.
What interventions are being tested in trial NCT06425094?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Microalgae Extract Capsules (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06425094?
This trial is sponsored by Colorado State University, which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.